Reena V. Jayani

Nov 7, 2024 | acsjournals.onlinelibrary.wiley.com | Reena V. Jayani |Canlan Sun |William Dale

REPLY Reply to “Assessing mental health impact on chemotherapy toxicity in older adults” Reena V. Jayani MD, MSCI,  Corresponding Author Reena V. Jayani MD, MSCI Vanderbilt University Medical Center, Nashville, Tennessee, USA Correspondence Reena V. Jayani, Vanderbilt University Medical Center, 2220 Pierce Avenue, 777 Preston Research Building, Nashville, TN 37232-6307, USA.

Jun 14, 2024 | nature.com | Rachel Gilmore |Bhagirathbhai Dholaria |Reena V. Jayani |Bipin N. Savani |Kendall Shultes |Dwight D. Eplin

AbstractThe age effect in severe aplastic anemia (SAA) following allogeneic hematopoietic cell transplantation (HCT) favors the use of reduced intensity conditioning (RIC) regimens in older adults. We implemented a non-myeloablative regimen consisting of fludarabine, cyclophosphamide, and rituximab (FCR) to improve HCT outcomes in SAA. Patients who underwent first HCT for SAA utilizing an FCR regimen between January 2016 and May 2022 were included.

Mar 10, 2024 | nature.com | Rahul Shah |Bipin N. Savani |Reena V. Jayani |Bhagirathbhai Dholaria

With identical major and minor human leukocyte antigen, how did GVHD develop in patients undergoing syngeneic- or auto-HCT? Glazier et al. [4] initially demonstrated in animal transplant models that the phenomenon indistinguishable from classic acute GVHD could develop in CsA-treated and lethally irradiated rats after syngeneic or autologous BM reconstitution.